Research Accelerator for Follicular Lymphoma I (RAFL-I)
The Leukemia & Lymphoma Society & The Institute for Follicular Lymphoma Innovation (IFLI)
UM Funding ID
FD03673
Sponsor
The Leukemia & Lymphoma Society & The Institute for Follicular Lymphoma Innovation (IFLI)
Category
International
Description
LLS and IFLI are jointly funding creative and ambitious research and development proposals under the RAFL program.
Two funding mechanisms available: Synergistic Team Awards (STA) offering up to $6.5M USD and Translational Awards (TRL) offering up to $1.75M USD for up to 5 years of funding.
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 09-Sep-2024 3:00 pm EST |
Application (Upon Invitation Only) | 02-Jan-2025 4:30 pm CST | 13-Jan-2025 3:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.